| Market Cap | ₹1,934Cr |
| ROE | 13.75% |
| P/E Ratio(TTM) | 18.14 |
| EPS(TTM) | 43.17 |
| P/B Ratio | 2.50 |
| Dividend Yield | 3.19% |
| Industry P/E | 39.81 |
| Book Value | 313.91 |
| Debt to Equity | 0.01 |
| Face Value | 5 |
| Parent Organisation | Novartis India Limited |
| Managing Director | Mr. Sanjay Murdeshwar |
| Founded | 1947 |
| BSE Symbol | 500672 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.94 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.07 | ||
| Wockhardt | NA (0.00%) | -439.39 | ||
| Cohance Lifesciences | NA (0.00%) | 64.75 |